New biotech Replay—led by former Pfizer and Bristol Myers Squibb executive Adrian Woolfson, Ph.D.—has unveiled with a $55 million seed financing to reprogram biology and author next generation genomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results